Chongqing Lummy Long Yu Pharmaceutical Co. ,Ltd

Voriconazole, Fludarabine phosphate, Eseomeprazole sodium, Eseomeprazole magnesium,Omeprazole magnesium, Aztreonam, Telmisartan,Mecobalamine,Terlivasopressin acetate,Carbetocin, Atosiban,Desmopressin acetate,Thymalfasin,Octreotide acetate, Degarelix,Ganirelix,Sincalide,Ziconotide Acetate,2'4' -difluoro-2 -[1-(1H-1,2, 4-triazolyl)] acetophenone,4-chloro-6-ethyl-5-fluoropyrimidine, etc

Chongqing Lummy Long Yu Pharmaceutical Co. ,Ltd

Country: China (Mainland)Business Type: Trading Company

Manufacturer

Premium supplierDiamond
supplier

qq

Contact US
Mr.tan
Tel: 15823366292
  • Fax: 023-40710538
  • URL: http://
  • Province/state: chongqing
  • City: changshou
  • Street:Chongqing
  • MaxCard:
About US
Chongqing Lummy Longyu Pharmaceutical Co.,Ltd. is a wholly-owned subsidiary of Chongqing Lummy Pharmaceutical Co.,Ltd., which was established in 1999 and listed on the Growth Enterprise Market in 2009.The headquarters is located in No. 2 Yangliu Road, Huangshan Avenue, Yubei District, Chongqing.
After nearly 20 years of development, the company has become a high-tech pharmaceutical enterprise integrating research and development, production and sales.The company has a rich product variety, with 88 varieties, 167 drug production approval documents.Among them, there are 16 API approvals, and the main products of the company cover anti-infection, specialty specialty (mainly including anti-tumor drugs, digestive system drugs, parenteral nutrition drugs), large infusion, Chinese patent medicine and prepared pieces, etc.
Chongqing laimei pharmaceutical raw material factory was established in 1999.
In 2011, a new API factory was built in Changshou Economic and Technological Development Zone (Changshou Economic and Technological Development Zone belongs to Changshou Economic and Technological Development Zone
National-level chemical industrial park), and complete the overall relocation of the raw material and pharmaceutical factory.
In December 2012, Changshou factory passed GMP certification and officially put into operation.
In 2015, it established a wholly-owned subsidiary and changed its name to Chongqing Lemay Longyu Pharmaceutical Co., Ltd.
The company is equipped with 4 chemical synthesis workshops, all equipped with conventional reaction tank, plate centrifuge, double-cone drying vacuum dryer and other conventional API synthesis equipment, without the national key supervision process.
Company equipped with four clean area, one of the workshop and the workshop clean production line according to C, B, (grade B + A) clean area design, equipped with dissolved decoloring cans, sterile filtration system, crystallizing tank, horizontal centrifugal machine, single cone, grinder, bin, repackaging RABS, VHP sterilization system, wet and heat sterilization system, dry heat sterilization system, etc.
The cleanliness level of workshop 3 and workshop 4 is designed according to the D level, equipped with conventional crystallization tank, centrifuge, powder crusher, dryer, etc., which can meet the routine production of common API.
Peptide project was established in 2012, Chongqing Lemay Longyu Pharmaceutical invested more than 20 million yuan to set up, and has a high-level peptide research and development team, mainly engaged in the production of peptide drugs and peptide drugs research and development.
The project team now has a complete production line of API and preparations, in which the production of API includes two parts: common area and clean area.At present, the main production equipment of polypeptide includes automatic synthesis instrument, automatic cleavage instrument, large-capacity refrigerated centrifuge, explosion-proof chromatography preparation instrument, purification chromatography column, automatic lyophilized drying machine and the corresponding supporting equipment;Another preparation of liquid phase, ultraviolet, infrared, moisture analyzer and other detection equipment.